Pharmaceuticals News

Vancouver, British Columbia--(Newsfile Corp. - May 11, 2021) - Amphotericin B Technologies, Inc ("Amp B Tech" or the "Company"), a wholly-owned subsidiary of iCo Therapeutics, Inc. (TSXV: ICO) ("iCo"), announced today that two presentations related to research on the effectiveness of the Company's Oral Amphotericin B formulation ("iCo 019")...
Biotechnology, Pharmaceuticals, Health
2021-05-11 8:00 AM EDT | iCo Therapeutics Inc.

Berwyn, Pennsylvania--(Newsfile Corp. - May 11, 2021) - Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer's disease (AD), Parkinson's disease (PD) and other neurodegenerative diseases, today announced that management will participate at the Benzinga Global Small Cap Conference taking place online May 13-14, 2021.Annovis Bio...
Biotechnology, Pharmaceuticals
2021-05-11 6:45 AM EDT | Annovis Bio, Inc.

Calgary, Alberta--(Newsfile Corp. - May 10, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) ("Hemostemix" or the "Company") announces it has closed its previously announced non-brokered private placement of units ("Units") announced on April 9, 2021, for gross proceeds of $440,031.90 (the "Offering"). The Offering consisted of the issuance of...
Biotechnology, Pharmaceuticals, Health
2021-05-10 10:16 PM EDT | Hemostemix Inc.

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - May 10, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") today announced it has retained Lytham Partners, LLC ("Lytham Partners") to lead an investor relations and shareholder communication program.For more than 20 years, Lytham Partners...
Pharmaceuticals, Cannabis, Cannabis Manufacturer, Cannabis Ancillary Service Provider
2021-05-10 4:00 PM EDT | Innocan Pharma Corporation

Berwyn, Pennsylvania--(Newsfile Corp. - May 10, 2021) -  Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer's disease (AD), Parkinson's disease (PD) and other neurodegenerative diseases, is pleased to announce that its CEO Maria Maccecchini, Ph.D. will ring The Closing Bell at the New York Stock...
Biotechnology, Pharmaceuticals
2021-05-10 2:00 PM EDT | Annovis Bio, Inc.

Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - May 10, 2021) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") today announced that the first patient has been enrolled in the COronary SInus Reducer for the Treatment of Refractory Microvascular Angina ("COSIMA") trial. The enrollment occurred at University...
Pharmaceuticals, Health
2021-05-10 9:05 AM EDT | Neovasc Inc.

San Diego, California--(Newsfile Corp. - May 10, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (FSE: 8FW) ("Tryp"), a pharmaceutical company focused on developing clinical-stage compounds for diseases with unmet medical needs, announced today a master service agreement with Clinlogix, a Contract Research Organization (CRO), to support Tryp's clinical devel
Biotechnology, Pharmaceuticals
2021-05-10 4:00 AM EDT | Tryp Therapeutics Inc.

Vancouver, British Columbia--(Newsfile Corp. - May 7, 2021) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"), a clinical stage biotech company dedicated to developing innovative treatments for nerve damage and neurodegenerative diseases, today announced that the Company has granted 800,000 incentive stock options to an Officer...
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2021-05-07 7:26 PM EDT | NervGen Pharma Corp.

Sandusky, Ohio--(Newsfile Corp. - May 7, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today released a preview of the company's plan to launch a CBD Nutraceuticals line of products. PAOG's CBD Nutraceuticals are expected to generate revenue this year, in 2021, while the company continues with its long-term...
Pharmaceuticals, Cannabis, Cannabis Cultivator, Cannabis Ancillary Service Provider
2021-05-07 8:42 AM EDT | PAO Group, Inc.

Vancouver, British Columbia--(Newsfile Corp. - May 7, 2021) - Defence Therapeutics Inc. (CSE: DTC) ("Defence" or the "Company"), a Canadian biotech Company focused on the development of novel and highly specific vaccines and antibody-drug conjugates targeting cancer and infectious diseases, is pleased to begin its trading on the CSE as...
Biotechnology, Pharmaceuticals, Health
2021-05-07 8:00 AM EDT | Defence Therapeutics Inc.

Calgary, Alberta--(Newsfile Corp. - May 6, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) ‎‎(FSE: 2VFO) ("Hemostemix" or the "Company") is pleased to announce that it has, subject to TSX Venture Exchange Approval, repriced to $0.55 each, and extended the exercise period for two years, the Warrants expiring May 7,...
Biotechnology, Pharmaceuticals, Health
2021-05-06 8:38 PM EDT | Hemostemix Inc.

Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - May 6, 2021) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), today reported financial results for the first quarter ended March 31, 2021.First Quarter HighlightsGenerated revenue of $451,794 in the quarter as Neovasc Reducer™ implants rebounded after being supp
Pharmaceuticals, Health
2021-05-06 4:05 PM EDT | Neovasc Inc.

Vancouver, British Columbia--(Newsfile Corp. - May 6, 2021) - Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) ("Nextleaf", "OILS", or the "Company"), the world's most innovative cannabis extractor, is pleased to announce the following updates around its CBD business:
Biotechnology, Pharmaceuticals, Cannabis, Cannabis Extractor
2021-05-06 9:00 AM EDT | Nextleaf Solutions Ltd.

Vancouver, British Columbia--(Newsfile Corp. - May 6, 2021) - BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") announces that online sales of its flagship VINIA® product in the United States will commence at 8 A.M. Eastern Time on May 12, 2021, via its vinia.com website.This milestone represents a turning...
Biotechnology, Pharmaceuticals, Cannabis, Cannabis Cultivator
2021-05-06 8:55 AM EDT | BioHarvest Sciences Inc.

Vancouver, British Columbia--(Newsfile Corp. - May 6, 2021) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"), a clinical stage biotech company dedicated to developing innovative treatments for nerve damage and neurodegenerative diseases, is pleased to announce today that the first subject has been dosed with NVG-291...
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2021-05-06 8:30 AM EDT | NervGen Pharma Corp.

Vancouver, British Columbia--(Newsfile Corp. - May 6, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is pleased to announce that it will be presenting at the Benzinga Global Small Cap Conference taking place on May 13-14, 2021. Philip Young, CEO and Director will be presenting on...
Technology, Pharmaceuticals, Health
2021-05-06 8:30 AM EDT | Lobe Sciences Ltd.

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - May 6, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce that it is currently trading on the OTCQB Venture Market and is eligible for electronic clearing and settlement through The Depository Trust...
Pharmaceuticals, Cannabis, Cannabis Manufacturer, Cannabis Ancillary Service Provider
2021-05-06 8:26 AM EDT | Innocan Pharma Corporation

Vancouver, British Columbia--(Newsfile Corp. - May 6, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") has entered into a license agreement (the "Agreement") with FlowerPod LLC ("FP"), a private US company, providing FP with the exclusive use of certain Emerald patented technology for developing and marketing cannabis...
Pharmaceuticals, Cannabis, Health, Cannabis Manufacturer
2021-05-06 7:00 AM EDT | Emerald Health Therapeutics, Inc.

Berwyn, Pennsylvania--(Newsfile Corp. - May 6, 2021) -  Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer's disease (AD), Parkinson's disease (PD) and other neurodegenerative diseases, today announced the U.S. Patent and Trademark Office (USPTO) granted the Company's patent (US 16/504,813) for a method of treating...
Biotechnology, Pharmaceuticals
2021-05-06 6:45 AM EDT | Annovis Bio, Inc.